Stroke Trials
@StrokeCliTrials
#StrokeTwitter
ID:3016121269
10-02-2015 04:05:34
3,6K Tweets
12,1K Followers
261 Following
Don't miss this month's editorial!
✍️📜 #Reperfusion therapy for #stroke : From improving global access, to #thrombectomy beyond 24 hours.
journals.sagepub.com/doi/full/10.11… Cambridge Stroke
Interested in learning more regarding predictors of hematoma expansion and response to andexanet alfa in patients with FXaI-associated ICH participating in the ANNEXa-I trial?
I summarize our findings with NeurologyLive here:
neurologylive.com/view/secondary…
#neurotwitter McMaster University Department of Medicine
Excited to be part of this American Heart Association scientific statement on #ArtificialIntelligence in #Cardiology with review, perils, pitfalls, and some thoughts on future directions👇
ahajournals.org/doi/epdf/10.11…
Kayte Spector-Bagdady Paul Friedman, MD Anne Kwitek Elle Lett transsexual enchantress negress, PhD Bijoy K Menon Katherine Sheehan, PhD ➡️
#STROKE March Cover Figure: Differential effects of tissue-type plasminogen activator ( #tPA ) originating from specific compartments during ischemic stroke thanks to #parabiosis in mice. #AHAJournals ahajrnls.org/49dbp7a Damien Levard. Institut BB@C
New sub-analysis of the SWIFT DIRECT Trial ➡️ #IVT in pts with anticipated emergent ICA stenting seemes safe: all❗️ pts w/ #tandem lesions achieved TICI2c-3 reperfusion; with no differences in mRS, mortality or sICH between EVT+IVT vs EVT-only groups. #GoLytics
onlinelibrary.wiley.com/doi/full/10.11…
Now Online!
🗞️Variations in the prevalence of #atrial #fibrillation , and in the strength of its association with ischemic #stroke , in countries with different income levels: INTERSTROKE case–control study.
journals.sagepub.com/doi/full/10.11… Robert Murphy
#STROKE Topical Review by Bérenger Largeau et al: Posterior reversible encephalopathy syndrome #PRES : benefits and limitations of current experimental models aiming to study #PRES pathophysiology and develop new therapies. #AHAJournals ahajrnls.org/3uCWCDP Stephan Ehrmann
Just Accepted!
📰 #Dabigatran etexilate versus #warfarin in cerebral venous #thrombosis in Chinese patients (CHOICE-CVT): an open-label, randomized controlled trial.
journals.sagepub.com/doi/abs/10.117… Cambridge Stroke
#LowerIsBetter 📉⬇️ Post-treatment level of LDL cholesterol and all-cause mortality in patients with atherosclerotic cardiovascular disease: evidence from real-world setting academic-oup-com.ezproxy.med.nyu.edu/eurjpc/article… Author Lay Summary 👉 “In this multicentre cohort comprising 33 968 patients at…
You can now read our latest paper
JAMA Network Open
The evidence from RCTs suggests that intensive post-EVT BP reduction does not yield benefits and may carry risks. Read more here: bit.ly/49K1RjL
Mohamed Elfil, MD Hassan Kobeissi Alzhraa Abbas, MD
MayoNeurovascularLab
Original Article: Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection nej.md/3wa2tAR
Editorial: Tenecteplase for Stroke — Opening the Window? nej.md/3OC0FXE
#EmergencyMedicine
One of the very exciting stories in secondary prevention of stroke in recent years. Excited to see what more we learn from ARCADIA. Hooman Kamel
jamanetwork.com/journals/jama/…
4/ Check out the full-length paper by Jim Siegler, Dad, Husband, MD Manisha Shadi Yaghi @AlmuftiFawaz Tareq Kass-Hout Thanh Nguyen 🇺🇦 available OPEN ACCESS here:
ahajournals.org/doi/10.1161/SV…
Hot off the heels of 3 paradigm shifting trial results of MMA embolization in cSDH, Michael Levitt, MD Josh Hirsch Michael Chen, MD review their results, impact, and upcoming future trials bit.ly/4bGT4AY #cSDH #mma